Abstract

Background
Uninsured individuals are found to have lower rates of human papillomavirus (HPV) vaccination initiation compared to insured patients. Our primary care clinic is based in an urban setting, and is primarily comprised of non-English-speaking and uninsured individuals. Previous review of the clinic’s HPV vaccination rate showed 13% of patients were fully vaccinated against HPV and 24% were partially vaccinated, lower than the national rates of 21.5% and 39.5%, respectively. This study aimed to improve the rate of HPV vaccination to meet the national average.
Methods

This retrospective chart review evaluated all males age 18-21 and females age 18-26 who attended a primary care visit at our clinic between January 1st 2021 to February 29th 2024. A quality improvement initiative was implemented from January 1st, 2023 to November 1st, 2023, and included educating the medical team, crafting informational pamphlets, and fostering discussions with patients. HPV vaccination rates were examined pre-intervention (January 1st, 2023-January 1st, 2023) and post-intervention (November 1st, 2023 to February 29th, 2024.

Results

379 patients were included in the pre-intervention group: 311 (82%) female, 68 (18%) male, and 93 patients were included post-intervention: 84 (90%) female and 9 (10%) male. The rate of patients fully vaccinated against HPV increased from 13% (n=51/379) from the pre-intervention group compared to 27% (n=27/93) in the post-intervention group. The rate of unvaccinated patients decreased from 63% (n=240/379) to 34% (n=32/93). This change in vaccination rates was statistically significant (p< 0.01).

Conclusion

Implementation of a quality improvement initiative to educate the medical staff and patients allowed for a statistically significant increase in the rate of HPV vaccination in an urban primary care practice. Continued collection of vaccination data from our clinic will allow for further guidance on how to target vaccine uptake in this population.

Disclosures

All Authors: No reported disclosures

This content is only available as a PDF.

Author notes

Study Group:

Session: 40. Adult Vaccines

Thursday, October 17, 2024: 12:15 PM

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Comments

0 Comments
Submit a comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.